BlackRock Amends AtriCure Stake: 13G/A Filing Shows Ownership Update
Ticker: ATRC · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1323885
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its AtriCure stake, signaling continued institutional interest.**
AI Summary
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, indicating a change in its beneficial ownership of AtriCure, Inc. common stock as of December 31, 2023. This filing, made on January 25, 2024, shows BlackRock continues to be a significant institutional holder, which can provide stability but also means large sales could impact the stock price. Investors should note that BlackRock's continued presence suggests a long-term interest in AtriCure's performance.
Why It Matters
This filing updates BlackRock's reported ownership in AtriCure, Inc., which is important because large institutional holdings can influence stock stability and investor sentiment.
Risk Assessment
Risk Level: low — This is a routine update from a major institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should monitor future 13G/A filings from BlackRock for significant changes in their ownership percentage, as a substantial increase or decrease could signal a shift in institutional confidence in AtriCure, Inc.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person filing the SC 13G/A
- AtriCure, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event which requires the filing of this statement
- January 25, 2024 (date) — the date the filing was made
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as stated in the 'FORM TYPE: SC 13G/A' and 'Amendment No: 7' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as indicated under '(1)Names of reporting persons. BlackRock, Inc.'.
What is the subject company whose securities are being reported?
The subject company is AtriCure, Inc., identified as 'ATRICURE INC (Name of Issuer)' and 'COMPANY CONFORMED NAME: AtriCure, Inc.'.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of AtriCure, Inc. is 04963C209, as listed under 'CUSIP No. 04963C209'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding AtriCure, Inc. (ATRC).